Markets2 min read

Cannabis ETFs Face Headwinds as 4/20 Rally Fails to Materialize

Cannabis-focused exchange-traded funds struggle with declining assets and investor fatigue as sector fundamentals remain challenged heading into peak season.

April 20, 2026 at 3:32 PMCannabismarketcap

Cannabis exchange-traded funds enter the traditional 4/20 peak season facing mounting pressure from sustained outflows and deteriorating sector fundamentals. The largest cannabis ETFs have shed billions in assets under management over the past two years as institutional and retail investors retreat from the space amid regulatory uncertainty and persistent profitability challenges across portfolio companies.

The AdvisorShares Pure US Cannabis ETF (MSOS) and ETFMG Alternative Harvest ETF (MJ) exemplify the sector's struggles, with both funds trading near multi-year lows despite containing exposure to major operators like Curaleaf, Green Thumb Industries, and Cresco Labs. Fund managers face the dual challenge of underlying company performance issues and broader market rotation away from speculative growth sectors that characterized much of the cannabis investment thesis.

Regulatory momentum around federal rescheduling has failed to provide the catalyst many ETF investors anticipated. While the DEA's review process continues, the timeline remains uncertain and potential benefits increasingly priced into current valuations. State-level market maturation has also compressed margins across key markets like California and Colorado, where oversupply and price competition have pressured the multi-state operators that form the core holdings of most cannabis ETFs.

Investor sentiment reflects broader disillusionment with cannabis as an investment category rather than temporary sector rotation. Fund flows data shows consistent monthly outflows from cannabis ETFs throughout 2024, suggesting institutional capital allocation has shifted toward other alternative investments with clearer regulatory pathways and stronger cash flow profiles.

The ETF structure itself presents additional challenges in cannabis markets, where liquidity constraints and limited public company options force funds into concentrated positions among a small group of operators. This concentration risk amplifies volatility during sector downturns while limiting diversification benefits that typically attract ETF investors seeking broad exposure to emerging industries.